Medicus Pharma CMO to lead Antev's Teverelix clinical programme
Yahoo Finance · Aug 3, 2026 · Medicus Pharma Ltd. Warrant (MDCXW)
Medicus Pharma (NASDAQ:MDCX) announced it has put its chief medical officer in charge of UK subsidiary Antev Limited, consolidating leadership of the Teverelix clinical programme ahead of regulatory, late-stage development and partnering work. Dr Faisal Mehmud will become Antev’s chief...
Not investment advice. Cached headline, not a full reprint.